MMI Raises $125M in Series D to Accelerate Commercial Growth of the Symani Surgical System Worldwide

JACKSONVILLE, FL — October 8, 2026 — MMI (Medical Microinstruments, Inc.), a robotics company dedicated to increasing treatment options and improving clinical outcomes for patients with complex conditions, today announced that it has raised $125 million in Series D financing.

The round was led by existing investor BioStar Capital, with participation from new investors S3 Ventures, Angelini Ventures, and an undisclosed strategic corporate investor. MMI’s existing investors also contributed, reflecting strong conviction in the company’s opportunity for continued growth and the expanding adoption of robotic microsurgery globally.

The financing comes as MMI enters its next stage of growth, with approximately 50 installed systems and 3,500 complex microsurgical procedures performed worldwide using the Symani® Surgical System. The capital will support MMI’s continued commercial expansion in the U.S. and key global markets, while strengthening the foundation needed to expand patient access. Investment in clinical trials and outcomes data, including the REMIND study, will also help expand the applications for Symani and support broader adoption.

“We’ve proven there is demand for robotic microsurgery at leading institutions around the world. Now, our focus is translating that adoption into scale,” said Mark Toland, CEO of MMI. “This investment gives us the ability to expand our reach, accelerate adoption and continue advancing the platform through innovation in areas like energy instruments and digital surgery capabilities.”

Scaling Robotic Microsurgery and Advancing New Possibilities

MMI was founded to transform open surgery by extending the capabilities of surgeons at the microsurgical level. As adoption grows, MMI is working with innovation-driven hospitals to develop robotic microsurgery programs designed to bring the capabilities of Symani to more surgeons and patients in need of delicate cancer and trauma-related reconstructive surgery and lymphatic and nerve repair options that improve quality of life…